Enliven Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELVN and other ETFs, options, and stocks.About ELVN
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002.
ELVN Key Statistics
Stock Snapshot
The current Enliven Therapeutics(ELVN) stock price is $58.94, with a market capitalization of 4.31B. The stock trades at a price-to-earnings (P/E) ratio of -35.25.
On 2026-08-16, Enliven Therapeutics(ELVN) stock traded between a low of $56.69 and a high of $58.94. Shares are currently priced at $58.94, which is +4.0% above the low and 0.0% below the high.
The Enliven Therapeutics(ELVN)'s current trading volume is 350.22K, compared to an average daily volume of 1.33M.
During the past year, Enliven Therapeutics(ELVN) stock moved between $14.79 at its lowest and $62.32 at its peak.
During the past year, Enliven Therapeutics(ELVN) stock moved between $14.79 at its lowest and $62.32 at its peak.
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.